Abacavir tablets Clinical Trials

• A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected Women
  ClinicalTrials.gov Identifier: NCT00000864 - Active, not recruiting
  HIV Infections
  
• Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)
  ClinicalTrials.gov Identifier: NCT00004981 - Active, not recruiting
  HIV Infections
  
• Four-Drug Combination Therapy with Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00006617 - Active, not recruiting
  HIV Infections
  
• Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) with Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00011895 - Active, not recruiting
  HIV Infections
  
• Comparison of GW433908/Ritonavir to Nelfinavir When Used with Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs
  ClinicalTrials.gov Identifier: NCT00009061 - Active, not recruiting
  HIV Infections
  
• Safety of and Immune Response to Cyclosporine A in Combination with Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in Adults with Acute HIV Infection
  ClinicalTrials.gov Identifier: NCT00084149 - Active, not recruiting
  HIV Infections
  
• Efavirenz Or Atazanazir/Ritonavir Given with Emtricitabine/Tenofovir Disoproxil Fumarate Or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
  ClinicalTrials.gov Identifier: NCT00118898 - Active, not recruiting
  HIV Infections
  
• Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-Release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic Pain
  ClinicalTrials.gov Identifier: NCT00410943 - Active, not recruiting
  Pain
  
• D4T or Abacavir Plus Vitamin Enhancement (DAVE)
  ClinicalTrials.gov Identifier: NCT00143702 - Recruiting
  Elevated Lactic Acid
  
• HLA-B*5701 And Hypersensitivity To Abacavir
  ClinicalTrials.gov Identifier: NCT00373945 - Active, not recruiting
  HIV
  
• PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets
  ClinicalTrials.gov Identifier: NCT00491998 - Recruiting
  Parkinson's Disease
  
• Clinical Utility Of Genetic Screening For HLA-B*5701, On Susceptibility To Abacavir Hypersensitivity
  ClinicalTrials.gov Identifier: NCT00340080 - Active, not recruiting
  HIV Infections
  
• Blood Levels of Abacavir in HIV Infected Adolescents
  ClinicalTrials.gov Identifier: NCT00087945 - Completed
  HIV Infections
  
• A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination
  ClinicalTrials.gov Identifier: NCT00335270 - Active, not recruiting
  HIV
  
• Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV
  ClinicalTrials.gov Identifier: NCT00244712 - Active, not recruiting
  HIV Infections
  
• Viral Dynamics and Pharmacokinetics of Abacavir and Tenofovir
  ClinicalTrials.gov Identifier: NCT00214890 - Recruiting
  HIV Infections
  
• Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection
  ClinicalTrials.gov Identifier: NCT00440947 - Active, not recruiting
  HIV Infection
  
• SHARE: Simple HAART With Abacavir, Reyataz, and Epivir
  ClinicalTrials.gov Identifier: NCT00426296 - Recruiting
  HIV Infections; Lipodystrophy
  
• Treatment with Combinations of Several Antiviral Drugs in Infants and Young Children with HIV Infection
  ClinicalTrials.gov Identifier: NCT00000872 - Active, not recruiting
  HIV Infections
  
• Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth
  ClinicalTrials.gov Identifier: NCT00102960 - Active, not recruiting
  HIV Infections
  
• A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy
  ClinicalTrials.gov Identifier: NCT00102206 - Active, not recruiting
  HIV Infections
  
• Anti-HIV Drugs During Pregnancy
  ClinicalTrials.gov Identifier: NCT00042289 - Active, not recruiting
  HIV Infections
  
• Oxycodone-Naloxone Prolonged Release Tablets in Relieving Opioid-Related Constipation
  ClinicalTrials.gov Identifier: NCT00412100 - Active, not recruiting
  Pain
  
• Evolution of L74V or K65R Mutations in VIremic Subjects on Tenofovir Disoproxil Fumarate (TDF) or Abacavir (ABC) (EVITA)
  ClinicalTrials.gov Identifier: NCT00312169 - Recruiting
  HIV Infections
  
• Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected with HIV
  ClinicalTrials.gov Identifier: NCT00000940 - Active, not recruiting
  HIV Infections
  
• A Study of Combivir plus Abacavir plus 141W94 in Patients Who Previously Have Used Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00002217 - Completed
  HIV Infections
  
• Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug Combination
  ClinicalTrials.gov Identifier: NCT00001132 - Completed
  HIV Infections
  
• HIV Study Of GW433908 Versus Kaletra, Both With Abacavir/lamivudine In Therapy-Naive Patients
  ClinicalTrials.gov Identifier: NCT00085943 - Active, not recruiting
  HIV Infections
  
• Blood Levels of Abacavir after One Dose in HIV-Infected Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00011479 - Completed
  HIV Infections
  
• Comparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral Therapy
  ClinicalTrials.gov Identifier: NCT00008554 - Active, not recruiting
  HIV Infections
  
• An Open-Label Evaluation of the Dose Proportionality of OROS® Hydromorphone HCL Tablets 8mg, 16mg, 32mg, 64mg
  ClinicalTrials.gov Identifier: NCT00398957 - Active, not recruiting
  Analgesia
  
• Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV
  ClinicalTrials.gov Identifier: NCT00086359 - Active, not recruiting
  HIV Infections
  
• Phase III Study to Assess the Long Term Efficacy, Carry-Over Effect and Safety of 300 IR Sublingual Immunotherapy Tablets
  ClinicalTrials.gov Identifier: NCT00418379 - Active, not recruiting
  Allergy
  
• Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients with Both HBV and HIV
  ClinicalTrials.gov Identifier: NCT00051090 - Active, not recruiting
  HIV Infections; Hepatitis B
  
• Sirolimus Blood Concentrations on Conversion From Oral Solution to Tablets
  ClinicalTrials.gov Identifier: NCT00166842 - Active, not recruiting
  Transplantation; Kidney Transplantation; Immunosuppression
  
• Long-Term Administration Study of SND 919 Tablets in Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00274131 - Active, not recruiting
  Parkinson Disease
  
• Changes in the Immune Response and Skin Reactivity of Grass Pollen Allergic Patients Treated With ALK Grass Tablets
  ClinicalTrials.gov Identifier: NCT00413556 - Active, not recruiting
  Allergy
  
• Changing to Nonprotease Inhibitor Treatment to Improve Side Effects
  ClinicalTrials.gov Identifier: NCT00021463 - Completed
  HIV Infections; Lipodystrophy
  
• A Study of Relapse Prevention and the Effectiveness of Long-Acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schiozaffective Disorder
  ClinicalTrials.gov Identifier: NCT00216476 - Active, not recruiting
  Schizophrenia; Psychotic Disorders
  
• A Repeated Dose Study of the Metabolism and Action Evaluation of OROS Hydromorphone HCI (Slow Release) Tablets in Patients With Chronic Pain
  ClinicalTrials.gov Identifier: NCT00410878 - Active, not recruiting
  Analgesics, Opioid.; Pain
  
• An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects with HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen
  ClinicalTrials.gov Identifier: NCT00002205 - Completed
  HIV Infections
  
• Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients
  ClinicalTrials.gov Identifier: NCT00028314 - Active, not recruiting
  HIV Infections; Lipodystrophy; Wasting Disease
  
• Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B
  ClinicalTrials.gov Identifier: NCT00324961 - Active, not recruiting
  Chronic Hepatitis B
  
• A Study of the Efficacy and Safety of Long-Acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00240708 - Active, not recruiting
  Schizophrenia
  
• Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy
  ClinicalTrials.gov Identifier: NCT00355082 - Active, not recruiting
  Epilepsy, Partial
  
• The STEAL Study
  ClinicalTrials.gov Identifier: NCT00192634 - Recruiting
  HIV
  
• Lopinavir Capsules to Kaletra or Invirase Tablets
  ClinicalTrials.gov Identifier: NCT00438152 - Recruiting
  HIV Infections
  
• When to Start Anti-HIV Drugs in Children Infected With HIV
  ClinicalTrials.gov Identifier: NCT00234091 - Recruiting
  HIV Infections
  
• Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment
  ClinicalTrials.gov Identifier: NCT00005017 - Active, not recruiting
  HIV Infections
  
• Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive Tablets
  ClinicalTrials.gov Identifier: NCT00553865 - Recruiting
  Essential Hypertension
  
• A MULTICENTER, OPEN-LABEL, RANDOMIZED CROSSOVER TRIAL TO ASSESS SUBJECT PREFERENCE FOR ALPRAZOLAM ORALLY DISINTEGRATING TABLETS COMPARED TO CONVENTIONAL ALPRAZOLAM TABLETS IN SUBJECTS WITH ANXIETY
  ClinicalTrials.gov Identifier: NCT00139854 - Completed
  Anxiety
  
• A Study to Compare Three Doses of T-20 When Given in Combination with Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults
  ClinicalTrials.gov Identifier: NCT00002239 - Completed
  HIV Infections
  
• Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy (Tablets) With Recombinant Bet v1
  ClinicalTrials.gov Identifier: NCT00396149 - Recruiting
  Allergy
  
• A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder
  ClinicalTrials.gov Identifier: NCT00326300 - Active, not recruiting
  Attention Deficit Hyperactivity Disorder
  
• A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults
  ClinicalTrials.gov Identifier: NCT00004585 - Completed
  HIV Infections
  
• Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment
  ClinicalTrials.gov Identifier: NCT00002419 - Completed
  HIV Infections
  
• Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis
  ClinicalTrials.gov Identifier: NCT00409409 - Recruiting
  Allergy
  
• Comparing the Effectiveness of a Triple Nucleoside Reverse Transcriptase Inhibitor Regimen Versus a Protease Inhibitor-Based Regimen In the Prevention of Mother-to-Child Transmission of HIV
  ClinicalTrials.gov Identifier: NCT00270296 - Recruiting
  HIV Infections
  
• Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail.
  ClinicalTrials.gov Identifier: NCT00356915 - Active, not recruiting
  Onychomycosis of the Toenail
  
• Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection
  ClinicalTrials.gov Identifier: NCT00013520 - Completed
  HIV Infections
  
• Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis
  ClinicalTrials.gov Identifier: NCT00078247 - Recruiting
  HIV Infections; Tuberculosis
  
• Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the Management of Break Through Pain
  ClinicalTrials.gov Identifier: NCT00463047 - Recruiting
  Chronic Pain
  
• Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients
  ClinicalTrials.gov Identifier: NCT00541385 - Recruiting
  Malaria
  
• Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00348309 - Recruiting
  Alzheimer Disease
  
• An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients.
  ClinicalTrials.gov Identifier: NCT00510211 - Recruiting
  Schizophrenia; Bipolar Disorder
  
• Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever: a Pilot Study.
  ClinicalTrials.gov Identifier: NCT00135629 - Active, not recruiting
  Seasonal Allergic Rhinoconjunctivitis
  
• Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With ITP
  ClinicalTrials.gov Identifier: NCT00441090 - Recruiting
  Chronic Idiopathic Thrombocytopenic Purpura (ITP)
  
• A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00002362 - Suspended
  HIV Infections
  
• Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)
  ClinicalTrials.gov Identifier: NCT00086203 - Active, not recruiting
  Chronic Lymphocytic Leukemia
  
• A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00001086 - Completed
  HIV Infections
  
• The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00141557 - Recruiting
  Menopause
  
• A Phase 3, Randomized, Open-Label, Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice-Daily Administration, When Co-Administered With NRTIs in Antiretroviral Naive HIV-1 Infected Subjects
  ClinicalTrials.gov Identifier: NCT00262522 - Active, not recruiting
  HIV Infection
  
• Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00348140 - Recruiting
  Alzheimer's Disease
  
• Rosiglitazone (Extended Release Tablets) Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00428090 - Recruiting
  Alzheimer's Disease
  
• A Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Dosing in Antiretroviral-Experienced, HIV-1 Infected Subjects
  ClinicalTrials.gov Identifier: NCT00358917 - Recruiting
  HIV Infection
  
• TMC278-TiDP6-C215: A Clinical Trial in Treatment naïve HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Abacavir + Lamivudine
  ClinicalTrials.gov Identifier: NCT00543725 - Not yet recruiting
  HIV-1; HIV Infections
  
• The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00141544 - Recruiting
  Menopause
  
• Long-Term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients
  ClinicalTrials.gov Identifier: NCT00263575 - Recruiting
  Pain; Cancer
  
• Efficacy and Safety of Sublingual Fentanyl Tablets in Treatment of Breakthrough Pain in Cancer Patients.
  ClinicalTrials.gov Identifier: NCT00262678 - Recruiting
  Pain; Cancer
  
• Fuzheng Huayu Tablets Against Posthepatitic Cirrhosis
  ClinicalTrials.gov Identifier: NCT00543426 - Recruiting
  Posthepatitic Cirrhosis
  
• A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection
  ClinicalTrials.gov Identifier: NCT00006154 - Not yet recruiting
  HIV Infections
  
• Post Marketing Surveillance Study to Observe Safety and Efficacy of Champix® Tablets
  ClinicalTrials.gov Identifier: NCT00483002 - Not yet recruiting
  Smoking Cessation
  
• Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn''s Disease
  ClinicalTrials.gov Identifier: NCT00130390 - Recruiting
  Crohn''s Disease
  
• Effect of Adjuvant Treatment With Compound Cranberry Extract Tablets in Acute Bacterial Cystitis.
  ClinicalTrials.gov Identifier: NCT00305071 - Not yet recruiting
  Pyuria; Urinary Tract Infections
  
• Study of TLK199 Tablets in Myelodysplastic Syndrome (MDS)
  ClinicalTrials.gov Identifier: NCT00280631 - Recruiting
  Myelodysplastic Syndrome (MDS)
  
• Effects of Cranberry-Containing Products in Women with Recurrent Urinary Tract Infections (UTIs)
  ClinicalTrials.gov Identifier: NCT00100061 - Recruiting
  Urinary Tract Infection
  
• A Study To Look At The Starting Dose Of Ropinirole Immediate Release Tablets In Young Patients With Restless Legs Syndrome
  ClinicalTrials.gov Identifier: NCT00140712 - Recruiting
  Restless Legs Syndrome
  
• Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD)
  ClinicalTrials.gov Identifier: NCT00434304 - Not yet recruiting
  Parkinson's Disease
  
• Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once Daily
  ClinicalTrials.gov Identifier: NCT00314626 - Completed
  HIV Infections
  
• Smoking Cessation With Smokeless Tobacco, Nicotine Tablets and Nicotine Patches
  ClinicalTrials.gov Identifier: NCT00313105 - Not yet recruiting
  Tobacco Dependence
  
• Oral CF101 Tablets and Methotrexate Treatment in Rheumatoid Arthritis Patients
  ClinicalTrials.gov Identifier: NCT00556894 - Not yet recruiting
  Rheumatoid Arthritis
  
• A Multicenter, Open-Label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects with Stable Parkinson''s Disease
  ClinicalTrials.gov Identifier: NCT00139867 - Completed
  Parkinson''s Disease
  
• Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Versus Multiple-Daily Dose Valproic Acid Capsules (Depakene) in Epilepsy:
  ClinicalTrials.gov Identifier: NCT00356018 - Not yet recruiting
  Epilepsy
  
• Phase II Comparator Study of Substitution of Tenofovir or Abacavir Receiving Thymidine Analogue as Part of HAART.
  ClinicalTrials.gov Identifier: NCT00270556 - Completed
  HIV
  
• Clinical Evaluation of Ropinirole CR-RLS ( SK&F106064)Tablets in Restless Legs Syndrome
  ClinicalTrials.gov Identifier: NCT00530790 - Not yet recruiting
  Restless Legs Syndrome
  
• Mycophenolate Mofetil and Abacavir Treatment in HIV Patients with Failed Anti-HIV Treatment
  ClinicalTrials.gov Identifier: NCT00021489 - Terminated
  HIV Infections
  
• Continued Antiretroviral Therapy with Abacavir, Amprenavir and Efavirenz
  ClinicalTrials.gov Identifier: NCT00001758 - Completed
  HIV Infection
  
• Comparison of Abacavir Following Once-Daily And Twice-Daily Administration In HIV Infected Subjects
  ClinicalTrials.gov Identifier: NCT00320307 - Completed
  HIV Infections
  
• Intravenous azithromycin plus intravenous ceftriaxone followed by oral azithromycin with intravenous levofloxacin followed by oral levofloxacin for the treatment of moderate to severely ill hospitalized patients with community acquired pneumonia.
  ClinicalTrials.gov Identifier: NCT00035347 - Completed
  Pneumonia
  
• Drug Interactions Among Anti-HIV Agents
  ClinicalTrials.gov Identifier: NCT00001766 - Completed
  HIV Infection